April 18, 2024, 03:05:05 PM
Forum Rules: Read This Before Posting


Topic: Allosteric regulation  (Read 7291 times)

0 Members and 1 Guest are viewing this topic.

Offline godfrey

  • Very New Member
  • *
  • Posts: 1
  • Mole Snacks: +0/-0
Allosteric regulation
« on: November 29, 2008, 01:21:29 PM »
    Pls, can anyone answer this question for me;

  Using feedback inhibition as a model,explain the general features of allosteric regulation!

Offline JGK

  • Chemist
  • Full Member
  • *
  • Posts: 738
  • Mole Snacks: +66/-19
  • Gender: Male
Re: Allosteric regulation
« Reply #1 on: November 29, 2008, 06:08:08 PM »
check the forum rules.

I would begin by examining the two processes of inhibition mentioned, then using the Feedback inhibition process highlight the similarities to, and differences from, the Allosteric inhibition process. there' plenty of basic information on the  web as well as your textbooks. 
Experience is something you don't get until just after you need it.

Offline limpet chicken

  • mad scientist
  • Full Member
  • ****
  • Posts: 750
  • Mole Snacks: +49/-27
  • Gender: Male
  • Vote Limpet for supreme emperor of the new order
Re: Allosteric regulation
« Reply #2 on: December 07, 2008, 09:24:40 PM »
Not sure about feedback inhibition (you mean negative feedback, of the kind done by autoreceptors like a2 adrenoreceptors or 5HT2a?)

But with allosteric regulation, you have two or more active sites on a receptor, the main agonist binding site, and one, or more, allosteric sites, a direct agonist/antagonist/inverse agonist binds to the main active site and does whatever it does at that receptor, opens/blocks/closes ion channels, activating second messengers and all that.

Direct agonists will cause a change in the activity of the receptor equal to their efficacy at that receptor, whilst an allosteric modulator binds to the allosteric site(s) and on its own, in the absence of a ligand bound to the main active site will cause no activity at the receptor, but when bound in the presence of a direct agonist will increase the maginitude of the response in the case of an positive modulator, and in the case of a negative modulator, decrease it, through indirect mechanisms such as changing the conformation of the receptor to one that binds with greater efficacy/affinity to the main binding site.


A good example would be the GABAa receptor.

The endogenous ligand is gamma-aminobutyric acid, GABA, which acts to open the ion channel, and pass chloride currents, decreasing general neuronal excitability, as its the main inhibitory neurotransmitter, the common sedative drugs of the benzodiazepine family bind to an allosteric site, changing the conformation of the receptor to one that binds with much higher efficacy to GABA, which in turn, causes an increased maximal stimulation of the receptor compared with that of GABA alone.

Different allosteric modulators can have different effects on channel conductance of course, with the benzodiazepines serving to increase channel opening frequency, whilst the far more dangerous barbiturates are also allosteric positive modulators at a different binding site, and both cause the ion channel to open more frequently, but to increase mean duration of the open state.

The light blinds
So behold darkness as our new light
In our darkness we can see
So with others blindness
We take flight.

Sponsored Links